AI Research and Policy Resources
Read the latest in AI research and discover policy resources. This section will be updated on a regular basis
EMA's "Artificial intelligence workplan to guide use of AI in medicines regulation" (December 2023)
EMA and the HMAs (Heads of Medicines Agencies) have published an artificial intelligence (AI) workplan to 2028, setting out a collaborative and coordinated strategy to maximise the benefits of AI to stakeholders while managing the risks.
The NHS AI Lab launched its new AI Dictionary (March 2022)
The NHS AI Lab launched its new AI Dictionary - A simple dictionary of common AI terms with a health and care context, with basic search and navigation
The NHS Artificial Intelligence Laboratory (NHS AI Lab) was created to address that challenge by bringing together government, health and care providers, academics and technology companies. You can find more information on its mission on their website.
EU Commission's Artificial Intelligence in Healthcare report (November 2021)
The Artificial Intelligence in Healthcare report provides an overview of national strategies, the uses and plans for AI in healthcare, and stakeholder views.
This study presents an overview of the development, adoption and use of Artificial Intelligence (AI) technologies and applications in the healthcare sector across all Member States. The main aim of this study was to support the European Commission in identifying and addressing any issues that might be hindering the wider adoption of AI technologies in the healthcare sector. The study will help the Commission to take action to achieve its long-term goal on the effective implementation of AI in the healthcare sector, based around common legislation and policy framework.
ICMRA Informal Innovation Network - Horizon Scanning Assessment Report - Artificial Intelligence (August 2021)
In this report, published in August 2021, the International Coalition of Medicines Regulatory Authorities (ICMRA) sets out recommendations to help regulators to address the challenges that the use of artificial intelligence (AI) poses for global medicines regulation.
European Commission Resource Page: A European Approach to Artificial Intelligence (July 2021)
The European Commission published its Resource Page on Artificial Intelligence where it is going to collect all the most relevant news on Artificial Intelligence in the frame of European policies and regulations.
WHO Guidance Document: ETHICS AND GOVERNANCE OF ARTIFICIAL INTELLIGENCE FOR HEALTH (June 2021)
Artificial intelligence (AI) has enormous potential for strengthening the delivery of health care and medicine and helping all countries achieve universal health coverage. This includes improved diagnosis and clinical care, enhancing health research and drug development and assisting with the deployment of different public health interventions, such as disease surveillance, outbreak response, and health systems management.
This WHO guidance document is the result of a two-year development process led by two Departments in the Science Division - Digital Health and Innovation and Research For Health. WHO has worked with a leading group of twenty experts to identify core principles to promote the ethical use of AI for health - these are the first consensus principles in this field.